Introduction
Hurler syndrome is an autosomal recessive disorder due to a severe deficiency in a-L-iduronidase activity, resulting in accumulation of substrates including heparan sulfate and dermatan sulfate. 1 Clinical manifestations of the disease are a consequence of the accumulation of these glycosaminoglycans (GAGs), resulting in corneal clouding, chronic rhinitis and otitis, obstructive airway disease, umbilical or inguinal hernia, progressive hepatosplenomegaly, cardiac disease, severe skeletal abnormalities, hydrocephalus and mental retardation. [2] [3] [4] A prominent feature of Hurler syndrome is developmental delay. Without intervention affected individuals reach a cognitive and developmental plateau and subsequently regress due to accumulation of storage material in the central nervous system (CNS). [5] [6] [7] With the availability of recombinant a-L-iduronidase (Laronidase), clinical trials evaluating its use have documented improvement in pulmonary and functional parameters, as well as other visceral changes. 8, 9 However, the i.v. delivery of iduronidase has limited ability to cross the blood-brain barrier. 10 Because of this allogeneic hematopoietic cell transplantation (HCT) remains the therapy of choice for young patients with severe iduronidase deficiency to maintain good cognitive function and to minimize the declining neurologic function in these children. 4, 11, 12 Whereas very good outcomes have been reported for patients with Hurler syndrome undergoing allogeneic transplantation, 11, 13, 14 other studies have been less encouraging, suggesting that more advanced patients with Hurler have inferior outcomes after transplantation. 5, 6, 12, 15 Several reports indicate that patients with Hurler syndrome may have a higher likelihood of pulmonary complications such as alveolar hemorrhage than patients of a similar age transplanted for other diseases. 16, 17 To address the question of whether high-risk groups can be identified before transplantation, we performed a retrospective analysis of 74 patients transplanted for Hurler syndrome at the University of Minnesota from 1990 to 2003. This group was identified as a cohort before the use of pre-transplantation enzyme was initiated at our institution as a prospective study beginning in 2004. 11 Parameters analyzed including the prevalence of hydrocephalus and a history of cardiac issues were not found to affect outcomes.
Although upper airway issues were not associated with a change in survival prior history of pulmonary disease including lower airway obstructive findings and a history of significant pneumonia correlated with a poorer post transplant outcome.
Patients and methods
Demographics of patients studied A total of 74 sequential patients with Hurler syndrome transplanted at the University of Minnesota from 1990 to 2003 were evaluated on this study. This is before the use of enzyme replacement therapy (ERT) for this disease. The diagnosis was confirmed based on deficient a-L-iduronidase activity and clinical parameters. All were recipients of an initial graft, using a myeloablative regimen. Patients were transplanted with a variety of graft sources, including related, unrelated donor and unrelated cord blood grafts ( Table 1) . The median cord blood cell dose was 6.1 Â 10 7 nucleated cells per kg, with a range of 3.2 to 19.0 Â 10 7 nucleated cells per kg. A mismatched unrelated donor was defined as any transplant using a donor mismatched at one locus based on the typing procedure currently in use at that time. Preparative regimens used included 34 patients who received BU and CY combination therapy, while 40 received CY and total body irradiation (TBI) (10 patients) or total lymphoid irradiation (30 patients). T-cell depletion using elutriation was performed in 44 patients (59%). As to outcome analysis, standard parameters including age, gender and CMV positivity (either in the donor or recipient) were analyzed.
Disease-specific potential risk factors analyzed
In an attempt to define possible high-risk categories in this patient population, the following potential risk factors were subjected to analysis ( Table 2 ). The identification of hydrocephalus before transplantation, based on MRI or CT criteria, was evaluated. In addition, as it had been previously suggested that the neurologic status before transplantation may influence outcome, we evaluated this parameter based on the Mental Development Index (MDI) from the Bayley Scale of Infant Development; patients were divided into those X70 and those o70. The potential of cardiac changes related to the underlying disease to affect survival was also investigated. The first of the cardiac measures related to an abnormal EKG, including prolongation of the PR interval, ST-T wave abnormalities, or evidence of ischemia or prior infarction. The second criterion included a history of heart failure, including the use of agents such as digoxin to improve cardiac function. Finally, a documented decrease in cardiac function, defined as a shortening fraction of p28%, or an ejection fraction p50% were evaluated regarding the outcome. The final group of risk factors investigated related to the role of respiratory difficulties before transplantation. Within this overall category, four factors of possible significance were evaluated. The first of these included a history of nonelective intubation for any reason, or difficulty in extubation following elective intubation. The second was specific to issues related to the upper airway, including a history of sleep apnea, or episodes of desaturation on a sleep study. In addition, a history of the child having noisy breathing or snoring during sleep was considered evidence of upper airway obstruction, as was the history of a tonsillectomy and/or adenoid surgery. The third category was a history of pneumonia of sufficient severity to require hospitalization. The final category related to a history of lower airway disease. Evidence of this was provided by a diagnosis of reactive airway disease, asthma or bronchiolitis. In addition, if the family observed 'wheezing', or wheezing was noted on examination, and this was not thought to be of upper airway origin, this was considered evidence of lower airway obstructive disease.
Risks of intubation in Hurler patients undergoing transplantation
Because patients with Hurler syndrome have appeared to have frequent pulmonary complications during the transplantation period, the incidence of intubation was determined. Factors potentially affecting the requirement for ventilatory support were analyzed using the same parameters used to assess survival.
Statistical methods
Univariate analysis of OS was performed at 1 and 5 years using Kaplan-Meier estimation. The cumulative incidence of intubation and of was grade II-IV acute GVHD was estimated by treating death as a competing risk. 
Results

Outcomes based on characteristics of transplantation
The OS of the entire population at 1 and 5 years was 63% and 53%, respectively (Table 3) . No significant differences were seen in survival analyses based on the type of graft, CMV status or conditioning regimen. However, in multiple regression analysis comparing the survival of mismatched unrelated donor recipients to those receiving other graft sources (matched unrelated donor, related donor or unrelated cord blood grafts), the relative risk (RR) for death following transplant was significantly higher (RR, 2.4; 95% CI, 1.1-5.0; P ¼ 0.02) for recipients of a mismatched URD transplant. The overall incidence of grade II-IV GVHD for the entire cohort was 36% (95% CI, . The use of T-cell depletion resulted in a decreased risk of II-IV GVHD when compared to transplantation using unmanipulated grafts (26%, 95% CI, 13-39; vs 52%, 95% CI, 33-71; Po0.01), but whether grafts were T cell depleted or not did not significantly impact OS. To evaluate the effect of age on survival, univariate determinations were performed using both 18 months and 2 years to define groups for analysis. No significance differences were seen in these age-related analyses. Unexpectedly, in outcome comparisons based on gender, the male patients had a significantly improved rate of survival than the female patients (77%, 95% CI, 63-90 vs 48%, 95% CI, 31-64; P ¼ 0.02). When male recipients were used as the reference category in multiple regression analysis, for females the relative risk was 2.34 (95% CI, 1.1-5.2; P ¼ 0.03). Regarding engraftment, no cases of primary graft failure, as defined by the lack of neutrophil recovery, was seen. However, in 10 cases autologous recovery was observed, 7 of which were in patients that had received T-cell-depleted (elutriated) grafts. If a successful transplant is defined as not only surviving but being engrafted based on chimerism studies, the proportion in this study that were engrafted and surviving at 1 year is 55% (95% CI, 43-65) and 47% (95% CI, 34-58) at 5 years. Within the group that was T cell depleted, the 1-and 5-year engrafted survival rate was 56% (95% CI 34-69) and 49% (95% CI, 33-63), respectively. This is similar to what was observed in the group receiving T-replete grafts, with the proportion of those surviving and engrafted 54% (95% CI, 34-69) and 43% (95% CI, 24-61) of the total at one and five years.
Survival based on neurologic and cardiac preexisting conditions Central nervous system manifestations of Hurler syndrome were evaluated using both radiographic and functional measures. The incidence of hydrocephalus in this group of patients was 18%. No differences in survival were seen in comparisons of groups that did or did not have hydrocephalus. As the natural history of Hurler syndrome reflects the slowing of developmental progress, we evaluated whether differences in survival outcomes could be determined using the MDI as a measure of cognition. The groups were divided into those with MDI470 and those below 70, a score which represents mild mental retardation. Data regarding MDI were available for 72 patients; the median MDI score was 88, with a range of 45-123. No differences in survival were noted in this analysis of MDI status. Related to cardiac criteria, only one patient was noted to have an abnormal EKG, and one a history of clinical cardiac dysfunction. However, 12 patients (16%) had documented decreased contractility based on low ejection fraction or shortening fraction determinations. This group did not have significantly worse survival than those without identified cardiac dysfunction.
Assessments of pre-transplant respiratory risk factors
The role of pulmonary issues before transplantation on outcome was analyzed in relation to the categories defined above. The proportion of patients with a history of nonelective intubation or upper airway obstructive disease was 14 and 37%, respectively. Neither category was associated with a significantly decreased rate of survival in this analysis. In contrast, the patients with Hurler syndrome who had pneumonia before transplant (15 of 73; 21%) had significantly worse survival than those that did not (Po0.01; Figure 1 ). Similarly, patients with a history of lower airway disease (9 of 73; 12%), were also shown to have inferior survival (Po0.01; Figure 2 ). Another approach to evaluate the effect of pulmonary issues is to assess their cumulative effect on survival. In this model, patients with no pulmonary complications were compared to those who had one or more criteria of any type. This analysis provided additional evidence that patients with more pulmonary complications were at higher risk for death following transplantation; this was not the case when a similar analysis was performed using cardiac criteria (Table 3) . Finally, if survival is evaluated in younger patients (p18 months of age) with or without pulmonary concerns before transplantation, outcomes are markedly superior to those with preidentified respiratory concerns ( Figure 3 ). It should be noted in several of the 'factors' listed, incomplete information was available to place all patients into risk categories. Therefore, the cumulative totals under these factors may not be 74, the total number of patients in the study. Similarly, in the 'Deaths' column, the death total may be less than the 33 patients that died, as some deaths could not be assigned to a risk category.
Events associated with intubation in the peri-transplant period Based on prior reports of frequent pulmonary complications in the Hurler population during transplantation, the incidence of intubation was determined. Of the 74 patients, 23 (31%) required ventilatory support in the 100 days following transplantation. The median day to intubation was 42 days (Figure 4 ). Alveolar hemorrhage was noted in seven of these patients (9% of all transplanted patients).
The type of graft, gender, conditioning regimen and CMV serostatus were not associated with an increased risk of intubation, although in multiple regression analysis the development of severe (grade III-IV) GVHD was a strong indicator of the risk of intubation (RR, 4.5; Po0.01). The use of T-cell depletion was found to decrease the risk of intubation (incidence 21%; 95% CI, 9-33) in comparison with those that did not receive a manipulated graft (incidence 45%; 95% CI, 27-63; P ¼ 0.01). The role of the preparative regimen was also examined related to the requirement for intubation during the transplant process.
In the group receiving either TBI or TLI (n ¼ 40) 12 process patients (30%) were intubated during the transplant, whereas of the 34 patients that had a chemotherapy-based regimen 11 (32%) were intubated (P ¼ 0.83). Older patients appeared to have an increased rate of respiratory insufficiency requiring intubation. Forty-four percent of those X18 months (95% CI, 27-61) required intubation, whereas 18% of patients o18 months were intubated (95% CI, 6-30; P ¼ 0.02). Similarly, the proportion of patients older than 2 years of age that required intubation was 55% (95% CI, 25-85), whereas those less than two years of age had an intubation rate of 27% (95% CI, 16-38; P ¼ 0.04).
Causes of death
Of the 33 patients that died, information related to the cause of death is available for 32 ( Figure 5 ). The largest proportion died of pulmonary issues (11 deaths; 34%). The second most common complication leading to death was infection, which included sepsis (n ¼ 5, 15%), fungal infections, specifically aspergillosis (n ¼ 3, 9%), and in one case a patient died of complications of an adenoviral infection. Four (12%) developed multiorgan system dysfunction, and GHVD was listed as the cause of death in three cases. Two patients died of complications from severe autoimmune hemolytic anemia. One patient died from each of the following complications; EBV lymphoproliferative disease, intracranial hemorrhage and complications from the primary disease.
Discussion
We report a single-institution retrospective analysis of the outcomes of patients with Hurler syndrome, defining pretransplantation parameters that can be used to assess risk categories for this population. The availability of recombinant iduronidase enzyme (Laronidase) has led to discussions regarding whether enzyme therapy may prove advantageous before transplantation. [11] [12] [13] 15, [18] [19] [20] [21] Based on this defining groups that could best benefit from ERT would be of importance. We found that none of the factors intrinsic to transplantation, such as the type of graft, preparative regimen, the use of T-cell depletion or CMV positivity affected survival. In assessing the role of disease-specific complications present before transplantation, we postulated that neurologic criteria may reflect the accumulation of GAGs in the CNS, and could thereby potentially be associated with survival. However, neither the presence of hydrocephalus nor an MDI of o70 was associated with significant differences in outcome in this analysis. Cardiac dysfunction was also evaluated, measured by a decreased shortening or ejection fraction, and no differences in survival were noted. Although a clinical history of heart failure or EKG abnormalities were also investigated, there were too few patients with these latter two parameters to provide a meaningful analysis. It should be noted that occasional patients undergoing transplantation for Hurler syndrome appear to die from complications that are cardiac related, and in several of these patients shows autopsy significant coronary artery changes due to their disease. It may be true that these changes are not identified by current pretransplant evaluations or by history, and therefore identifying high-risk patients is difficult.
It has previously been suggested that respiratory complications can lead to significant complications during transplantation for Hurler syndrome. 13, 16, 17 In addition, a high incidence of airway-related concerns exists in this population, [22] [23] [24] complicating anesthesia and increasing the risk of morbidity associated with transplantation. To determine if preexisting respiratory issues affected the risk of transplantation, we defined four broad categories, as outlined in Table 2 . Two of these categories, a history of nonelective intubation and upper airway concerns, were not associated with a higher mortality rate. In contrast, categories reflective of lower airway disease, including a history of pneumonia or evidence of lower airway obstructive disease, were correlated with poor outcomes. In this series, a relatively high proportion of the deaths that were observed were attributed to pulmonary complications as well. It has been suggested that alveolar hemorrhage is prominent in Hurler patients undergoing transplantation. 17 In the present series the incidence of alveolar hemorrhage was 9% of all patients transplanted, higher than in some reports, 12,13 whereas others have also described a high risk of hemorrhage. 17 However, a clear diagnosis of alveolar hemorrhage may be difficult to document, and a high rate of pulmonary bleeding has been defined on autopsy in recipients of cord blood transplantation. 25 It is possible that inflammatory changes noted in these patients contribute to respiratory complications after transplantation. 16 In addition, we have recently described that the presence of GAGs may act as an anticoagulant, which could contribute to hemorrhage during transplantation. 26 An additional factor may be the relatively high proportion of patients that received radiation as part of their pre-transplant conditioning in our study, which is different than many centers, which have used chemotherapy-only regimens. It is of interest that the older-age groups were more likely to require intubation as they underwent transplantation. This may suggest that the overall burden of storage material may contribute to airway dysfunction, or to the pathophysiology of lung injury. There is evidence that outcomes with transplantation for Hurler syndrome have improved over the past decade. 11, 12, 14, 21, 27 It should be noted in a discussion of the morbidity and mortality associated with transplantation that supportive care, including targeting of BU levels, improved antiviral and antifungal therapy, better means of HLA matching and so on have the potential to improve outcomes. Based on this, current results with transplantation are likely to be better than what were achieved historically. Ultimately, the question as to whether enzyme replacement may decrease overall morbidity and mortality of transplantation, or difficulties specifically due to pulmonary complications, or risks associated with patients undergoing transplantation at an older age will require additional study. In one report no clear benefit was obtained with peri-transplantation ERT, 12 whereas this was not the case in another study. 11 However, it seems clear that transplantation at an earlier age is beneficial, making timely diagnosis an important goal. The observed effect of gender on OS in patients with Hurler syndrome was unexpected. In this analysis it was consistent in both univariate and multiple regression analyses. However, others have not observed differences based on gender. 15 No difference in the incidence of intubation was noted based on gender, nor were there clear differences in the events leading to death (data not shown). The reasons for this observation remain unclear, and will require further monitoring.
In summary, more recent data suggest that very good outcomes can be obtained with allogeneic hematopoietic SCT for young patients with Hurler syndrome. [11] [12] [13] [14] 21 The availability of ERT provides an opportunity for an additional therapeutic intervention until engraftment is achieved. Although there has been concern that the use of enzyme may increase the risk of nonengraftment, thus far there is no evidence to support this. 11, 12, 14, 21 Our approach has been to offer ERT before and after transplantation until engraftment is achieved for all patients, although others have suggested that it should only be used for selected patients, and still others have suggested it not be used at all, instead proceeding to transplantation as quickly as possible. The data presented here suggest that high-risk populations of Hurler patients can be identified based on pulmonary symptomatology before transplantation. Based on this, it would seem prudent to consider enzyme therapy for at least these groups.
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